About the Startup
Biopharma company focused on neuropsychiatric disorders developing Deraphan, a combination therapy for Alzheimer-related agitation.
Frequently Asked Questions
What type of funding round did Exciva GmbH raise?
Exciva GmbH raised a series-b round.
How much did Exciva GmbH raise in its series-b?
Exciva GmbH raised $51,000,000 USD in its series-b.
When did Exciva GmbH raise its series-b?
Exciva GmbH raised its series-b on 2026-01-20.
Who invested in Exciva GmbH's series-b?
The investors in Exciva GmbH's series-b are: Gimv, EQT Life Sciences, Andera Partners, Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi VC, LBBW.
What type of investment was Exciva GmbH's series-b?
Exciva GmbH's series-b was a equity investment.